Trade ICU Medical Inc - ICUI CFD
Add to favourite- Summary
- Historical Data
| Spread | 1.15 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023346% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001124% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 0.1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 166.82 |
| Open | 163.64 |
| 1-Year Change | 73.49% |
| Day's Range | 163.64 - 167.05 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jan 21, 2025 | 166.82 | 2.75 | 1.68% | 164.07 | 166.85 | 164.05 |
| Jan 17, 2025 | 163.47 | -2.19 | -1.32% | 165.66 | 166.82 | 160.70 |
| Jan 16, 2025 | 166.01 | 4.86 | 3.02% | 161.15 | 168.25 | 160.96 |
| Jan 15, 2025 | 166.38 | 4.40 | 2.72% | 161.98 | 166.66 | 160.66 |
| Jan 14, 2025 | 160.96 | 3.42 | 2.17% | 157.54 | 161.03 | 157.37 |
| Jan 13, 2025 | 158.08 | 7.75 | 5.16% | 150.33 | 158.86 | 150.33 |
| Jan 10, 2025 | 154.14 | -0.85 | -0.55% | 154.99 | 158.31 | 153.42 |
| Jan 8, 2025 | 160.67 | 0.71 | 0.44% | 159.96 | 161.91 | 155.78 |
| Jan 7, 2025 | 161.93 | -2.59 | -1.57% | 164.52 | 165.96 | 160.13 |
| Jan 6, 2025 | 164.67 | 4.01 | 2.50% | 160.66 | 165.08 | 160.66 |
| Jan 3, 2025 | 160.16 | 7.52 | 4.93% | 152.64 | 162.30 | 152.64 |
| Jan 2, 2025 | 157.83 | 2.27 | 1.46% | 155.56 | 159.15 | 152.97 |
| Dec 31, 2024 | 154.91 | -0.03 | -0.02% | 154.94 | 156.37 | 151.00 |
| Dec 30, 2024 | 154.39 | 1.44 | 0.94% | 152.95 | 154.69 | 150.98 |
| Dec 27, 2024 | 154.24 | -0.91 | -0.59% | 155.15 | 156.48 | 152.07 |
| Dec 26, 2024 | 156.32 | 2.14 | 1.39% | 154.18 | 157.10 | 152.63 |
| Dec 24, 2024 | 156.45 | 2.98 | 1.94% | 153.47 | 156.90 | 152.26 |
| Dec 23, 2024 | 154.44 | 1.06 | 0.69% | 153.38 | 156.67 | 151.24 |
| Dec 20, 2024 | 156.67 | 5.03 | 3.32% | 151.64 | 157.74 | 150.33 |
| Dec 19, 2024 | 152.70 | -0.35 | -0.23% | 153.05 | 155.30 | 151.53 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
ICU Medical Company profile
About ICU Medical Inc
ICU Medical, Inc. (ICU) is engaged in the development, manufacturing and sale of medical products used in infusion therapy and critical care applications. The Company’s product portfolio includes IV solutions, IV smart pumps with pain management and safety software technology, dedicated and non-dedicated IV sets and needlefree connectors designed to help meet clinical, safety and workflow goals. Its critical care products help clinicians get real-time access to patients’ hemodynamic and cardiac status with a portfolio of monitoring systems and advanced sensors and catheters. Its primary critical care products include Cogent, CardioFlo, TDQ and OptiQ, TriOx, Transpac and SafeSet. It sells its products through its direct sales force and through independent distributors. Its IV Solutions products include IV Therapy and Diluents, and Irrigation. Its Infusion System products include Infusion Pump Hardware, IV Mediation Safety Software and Professional Services.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, ICU Medical Inc revenues increased 4% to $1.32B. Net income increased 19% to $103.1M. Revenues reflect Infusion Consumables segment increase of 17% to $555.2M, Critical Care segment increase of 1% to $49.3M, United States segment increase of 3% to $941.8M, EMEA segment increase of 11% to $147.5M. Net income benefited from Restructuring Charges/Provisions decrease of 37% to $18M (expense).
Equity composition
Common Stock $.10 Par, 03/11, 80M auth., 14,855,000 issd., less 1,123,000 shs. in Treas @ $38.95M. Insiders & Strategic holders own 11.33%. IPO 3/92, 1.3M shares @ $11.00 by Sutro& Co., Inc. PO 7/95, 2.07M shares @ $12 by Rodman & Renshaw, Inc. 3/02, 4/93, 3-for-2 stock splits. FY'03 Q4 are being restated.
| Industry: | Medical Equipment, Supplies & Distribution (NEC) |
951 Calle Amanecer
SAN CLEMENTE
CALIFORNIA 92673-6212
US
News
MELANIA coin ($MELANIA) price prediction: Third party price target
Read our MELANIA crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts.
11:33, 22 January 2025
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025
Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
12:40, 31 December 2024
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024
Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024
Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024People also watch
Still looking for a broker you can trust?
Join the 680,000+ traders worldwide that chose to trade with Capital.com